Literature DB >> 16793892

Zinc-dependent multi-conductance channel activity in mitochondria isolated from ischemic brain.

Laura Bonanni1, Mushtaque Chachar, Teresa Jover-Mengual, Hongmei Li, Adrienne Jones, Hidenori Yokota, Dimitry Ofengeim, Richard J Flannery, Takahiro Miyawaki, Chang-Hoon Cho, Brian M Polster, Marc Pypaert, J Marie Hardwick, Stefano L Sensi, R Suzanne Zukin, Elizabeth A Jonas.   

Abstract

Transient global ischemia is a neuronal insult that induces delayed cell death. A hallmark event in the early post-ischemic period is enhanced permeability of mitochondrial membranes. The precise mechanisms by which mitochondrial function is disrupted are, as yet, unclear. Here we show that global ischemia promotes alterations in mitochondrial membrane contact points, a rise in intramitochondrial Zn2+, and activation of large, multi-conductance channels in mitochondrial outer membranes by 1 h after insult. Mitochondrial channel activity was associated with enhanced protease activity and proteolytic cleavage of BCL-xL to generate its pro-death counterpart, deltaN-BCL-xL. The findings implicate deltaN-BCL-xL in large, multi-conductance channel activity. Consistent with this, large channel activity was mimicked by introduction of recombinant deltaN-BCL-xL to control mitochondria and blocked by introduction of a functional BCL-xL antibody to post-ischemic mitochondria via the patch pipette. Channel activity was also inhibited by nicotinamide adenine dinucleotide, indicative of a role for the voltage-dependent anion channel (VDAC) of the outer mitochondrial membrane. In vivo administration of the membrane-impermeant Zn2+ chelator CaEDTA before ischemia or in vitro application of the membrane-permeant Zn2+ chelator tetrakis-(2-pyridylmethyl) ethylenediamine attenuated channel activity, suggesting a requirement for Zn2+. These findings reveal a novel mechanism by which ischemic insults disrupt the functional integrity of the outer mitochondrial membrane and implicate deltaN-BCL-xL and VDAC in the large, Zn2+-dependent mitochondrial channels observed in post-ischemic hippocampal mitochondria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793892      PMCID: PMC4758341          DOI: 10.1523/JNEUROSCI.5444-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  94 in total

1.  Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia.

Authors:  T Sugawara; M Fujimura; Y Morita-Fujimura; M Kawase; P H Chan
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

2.  Modulation of synaptic transmission by the BCL-2 family protein BCL-xL.

Authors:  Elizabeth A Jonas; Daniel Hoit; John A Hickman; Teresa A Brandt; Brian M Polster; Yihru Fannjiang; Erin McCarthy; Marlena K Montanez; J Marie Hardwick; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

Review 3.  Zinc-containing neurons in hippocampus and related CNS structures.

Authors:  C J Frederickson; G Danscher
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

4.  Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria.

Authors:  C R Hackenbrock
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

5.  Enhanced spontaneous transmitter release is the earliest consequence of neocortical hypoxia that can explain the disruption of normal circuit function.

Authors:  I A Fleidervish; C Gebhardt; N Astman; M J Gutnick; U Heinemann
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

6.  Exposure to hypoxia rapidly induces mitochondrial channel activity within a living synapse.

Authors:  Elizabeth A Jonas; John A Hickman; J Marie Hardwick; Leonard K Kaczmarek
Journal:  J Biol Chem       Date:  2004-11-23       Impact factor: 5.157

7.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

8.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

9.  Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.

Authors:  N Fujita; A Nagahashi; K Nagashima; S Rokudai; T Tsuruo
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

10.  Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis.

Authors:  T Nakagawa; J Yuan
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

View more
  45 in total

Review 1.  The neurophysiology and pathology of brain zinc.

Authors:  Stefano L Sensi; Pierre Paoletti; Jae-Young Koh; Elias Aizenman; Ashley I Bush; Michal Hershfinkel
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  The role of zinc in cerebral ischemia.

Authors:  Sherri L Galasso; Richard H Dyck
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

Review 3.  Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death.

Authors:  Yumin Zhang; Elias Aizenman; Donald B DeFranco; Paul A Rosenberg
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

4.  Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury.

Authors:  Gali Umscheif; Gali Umschwief; Na'ama A Shein; Alexander G Alexandrovich; Victoria Trembovler; Michal Horowitz; Esther Shohami
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

5.  The interactive roles of zinc and calcium in mitochondrial dysfunction and neurodegeneration.

Authors:  Natalia B Pivovarova; Ruslan I Stanika; Galina Kazanina; Idalis Villanueva; S Brian Andrews
Journal:  J Neurochem       Date:  2013-11-04       Impact factor: 5.372

6.  Rapid Intramitochondrial Zn2+ Accumulation in CA1 Hippocampal Pyramidal Neurons After Transient Global Ischemia: A Possible Contributor to Mitochondrial Disruption and Cell Death.

Authors:  Hong Z Yin; Hwai-Lee Wang; Sung G Ji; Yuliya V Medvedeva; Guilian Tian; Afsheen K Bazrafkan; Niki Z Maki; Yama Akbari; John H Weiss
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

7.  Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency.

Authors:  Kambiz N Alavian; Steven I Dworetzky; Laura Bonanni; Ping Zhang; Silvio Sacchetti; Maria A Mariggio; Marco Onofrj; Astrid Thomas; Hongmei Li; Jamie E Mangold; Armando P Signore; Ulrike Demarco; Damon R Demady; Panah Nabili; Emma Lazrove; Peter J S Smith; Valentin K Gribkoff; Elizabeth A Jonas
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

Review 8.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

9.  Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons.

Authors:  Takahiro Miyawaki; Toshihiro Mashiko; Dimitry Ofengeim; Richard J Flannery; Kyung-Min Noh; Sho Fujisawa; Laura Bonanni; Michael V L Bennett; R Suzanne Zukin; Elizabeth A Jonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

10.  Bcl-xL inhibitor ABT-737 reveals a dual role for Bcl-xL in synaptic transmission.

Authors:  John A Hickman; J Marie Hardwick; Leonard K Kaczmarek; Elizabeth A Jonas
Journal:  J Neurophysiol       Date:  2007-12-26       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.